Likely, we primarily characterized immune signatures with PD-L1 expression in patients with lung adenocarcinoma from TCGA-LUAD database and found that the percentage of high-grade immune subtypes (C3-C5) in PD-L1 high group was higher than PD-L1 low group. The gene discussed is CD274; the disease is lung adenocarcinoma.